ACDIMA

The Arab Company for Drug Industries and Medical Appliances, since 1976.

ACDIMA is an Egyptian investment corporate specialized in healthcare industries. We have successfully secured the availability of essential pharmaceutical products through; integration, self-sufficiency and reasonably priced products.

Over the recent years ACDIMA became the strongest arm supporting the Egyptian Pharmaceutical industries. ACDIMA products exist in 55 countries in Europe, CIS, Africa and the Middle East.

The company’s pioneering role in the field of pharmaceutical industries and strengthening its position as one of the strong and important entities of the state in the face of any crises facing the pharmaceutical industry in Egypt, with the advancement, development and settlement of this industry as an important element of the Egyptian national security.

Projects

ACDIMA is coordinating and cooperating with the Ministry of Health and relevant authorities, such as the Egyptian Medicines Authority and the Unified Procurement Authority, in providing some strategic and essential medicines for the Egyptian patient, as well as medicines that have a noticeable shortage in the local medicine market, by producing some medicines similar to these deficiencies and doubling production quantities with import for others if non-manufacturing.

exhibitors-certificate-africa-health-excon-77

ACDIMA in Africa Health ExCon

The first African Medical Conference and Exhibition «Africa Health ExCon» was held under the auspices of President Abdel Fattah Al-Sisi from June 5 to 7, 2022 in Cairo. Acdima Company, headed by Dr. Olfat Ghorab, and a delegation from Acdima sister and affiliated companies attended

ACDIMA

The Arab Company for Drug Industries and Medical Appliances, since 1976.

ACDIMA is an Egyptian investment corporate specialized in healthcare industries. We have successfully secured the availability of essential pharmaceutical products through; integration, self-sufficiency and reasonably priced products.

Over the recent years ACDIMA became the strongest arm supporting the Egyptian Pharmaceutical industries. ACDIMA products exist in 55 countries in Europe, CIS, Africa and the Middle East.

The company’s pioneering role in the field of pharmaceutical industries and strengthening its position as one of the strong and important entities of the state in the face of any crises facing the pharmaceutical industry in Egypt, with the advancement, development and settlement of this industry as an important element of the Egyptian national security.

Projects

ACDIMA is coordinating and cooperating with the Ministry of Health and relevant authorities, such as the Egyptian Medicines Authority and the Unified Procurement Authority, in providing some strategic and essential medicines for the Egyptian patient, as well as medicines that have a noticeable shortage in the local medicine market, by producing some medicines similar to these deficiencies and doubling production quantities with import for others if non-manufacturing.

ACDIMA Award

Research and Development is one of the main pillars to improve Egypt’s social and economical position, that’s why ACDIMA is focused on enhancing Egyptian research and development by providing our annual ACDIMA Award in science and applied pharmaceutical industry to winners.

ACDIMA GENERAL ASSEMBLY

ACDIMA General Assembly for year 2021

ACDIMA & Cuba

Dr. Khaled Abdel Ghaffar, Minister of Health and Population, announced the start of a new phase of fruitful cooperation between Egypt and Cuba, by exporting Egyptian human insulin, known as “Insulinagypt,” from Egypt to Cuba.

Dr. Olfat Ghorab: We are implementing a comprehensive strategy to localize the pharmaceutical industry in Egypt with the strength of our financial and operational structure and the absolute support of the country.

General Assembly of ACDIMA

The Minister of Health emphasizes the role of “ACDIMA” in developing and localizing pharmaceutical industries in accordance with the latest international standards.

During the company’s general assembly meeting, Dr. Olfat Ghorab, Chairman of the Board of Directors of the Arab Company for Drug Industries and Medical Appliances “ACDIMA”, reviewed ACDIMA’s efforts and achievements during the year 2023, which was achieved to meet the pharmaceutical needs in the Egyptian market and implementing strategies to serve patients.

Under the auspices of “Acdima International” … “The Ministry of Health” launches the largest training program for gynecologists and obstetrics.

ACDIMA Award 2022

Winners of ACDIMA Award receiving their award at ACDIMA.

ACDIMA in CPHI 2023

ACDIMA participation in CPHI 2023 in Barcelona.

ACDIMA & Kazakhstan

A delegation from the largest pharmacy company in Kazakhstan visits ACDIMA to discuss joint cooperation.

ACDIMA & Kazakhstan

“ACDIMA” One of the Largest Pharmaceutical Holdings in the Middle East is Planning to Build a Plant in Kazakhstan

ACDIMA & Uzbekistan

National Day of Egypt

Tashkent – July 17,2023

31 Years of diplomatic relations between Egypt and Uzbekistan.

ACDIMA & Aamal holding - Qatar

ACDIMA signs a cooperation protocol with “Aamal Holding – Qatar” to transfer pharmaceutical manufacturing technology and promote Egyptian medicine in Qatar.

AFRICA Health ExCon 2023

Unified Procurement Authority Launches Africa Health ExCon “Your Gateway to Innovation” – Introductory Conference

SEDICO - Trial operation of the oncology drug factory

In a step that contributes to achieving national and health security
SEDICO Pharmaceutical Industries, one of the companies of the ACDIMA Group, begins the trial operation of the first factory for the production of oncology drugs in Egypt, with investments up to one billion pounds.

SEDICO's visit

The Minister of Health visits SEDICO’s factory, which specializes in the production of cytotoxics preparations.

MUP's visit

The Minister of Health inspects MUP Tech factory specialized in Insulin VL & Carpules.

ACDIMA & SRTA-City

A protocol of co-operation was signed between ACDIMA and SRTA-City.

The signature of cooperation protocol between City of Scientific Research and Technological Applications and ACDIMA which is known for its great support for educational institutions in the fields of training and scientific research.

ACDIMA & Future University in Egypt

A protocol of co-operation was signed between ACDIMA and FUE.

The signature of cooperation protocol between FUE and ACDIMA which is known for its great support for educational institutions in the fields of training and scientific research.

ACDIMA

since 1976

ACDIMA is an Egyptian investment corporate specialized in healthcare industries. We have successfully secured the availability of essential pharmaceutical products through; integration, self-sufficiency and reasonably priced products.

Over the recent years ACDIMA became the strongest arm supporting the Egyptian Pharmaceutical industries. ACDIMA products exist in 55 countries in Europe, CIS, Africa and the Middle East.

The company’s pioneering role in the field of pharmaceutical industries and strengthening its position as one of the strong and important entities of the state in the face of any crises facing the pharmaceutical industry in Egypt, with the advancement, development and settlement of this industry as an important element of the Egyptian national security.

Projects

ACDIMA is coordinating and cooperating with the Ministry of Health and relevant authorities, such as the Egyptian Medicines Authority and the Unified Procurement Authority, in providing some strategic and essential medicines for the Egyptian patient, as well as medicines that have a noticeable shortage in the local medicine market, by producing some medicines similar to these deficiencies and doubling production quantities with import for others if non-manufacturing.

ACDIMA

ACDIMA is an Egyptian investment corporate specialized in healthcare industries. We have successfully secured the availability of essential pharmaceutical products through; integration, self-sufficiency and reasonably priced products.

Over the recent years ACDIMA became the strongest arm supporting the Egyptian Pharmaceutical industries. ACDIMA products exist in 55 countries in Europe, CIS, Africa and the Middle East.

The company’s pioneering role in the field of pharmaceutical industries and strengthening its position as one of the strong and important entities of the state in the face of any crises facing the pharmaceutical industry in Egypt, with the advancement, development and settlement of this industry as an important element of the Egyptian national security.

ACDIMA Award

Research and Development is one of the main pillars to improve Egypt’s social and economical position, that’s why ACDIMA is focused on enhancing Egyptian research and development by providing our annual ACDIMA Award in science and applied pharmaceutical industry to winners.

Projects

ACDIMA is coordinating and cooperating with the Ministry of Health and relevant authorities, such as the Egyptian Medicines Authority and the Unified Procurement Authority, in providing some strategic and essential medicines for the Egyptian patient, as well as medicines that have a noticeable shortage in the local medicine market, by producing some medicines similar to these deficiencies and doubling production quantities with import for others if non-manufacturing.

ACDIMA in Africa Health ExCon

The first African Medical Conference and Exhibition «Africa Health ExCon» was held under the auspices of President Abdel Fattah Al-Sisi from June 5 to 7, 2022 in Cairo. Acdima Company, headed by Dr. Olfat Ghorab, and a delegation from Acdima sister and affiliated companies attended

Our Companies

Group Business

Pharmaceutical Production

High quality essential products covering all therapeutic classes.

Marketing and distribution inside Egypt and exporting all over the world.

Diversified business covering primary and secondary packaging materials.

R&D and clinical research supporting healthcare services in Egypt and the region.

Investor Information

From Egypt to the world: Being the largest health care investment organization in Egypt, ACDIMA is well positioned in both developing and developed markets globally. We now have an expanding presence in Africa, Middle east, Europe and CIS countries.

We have a proud legacy dating back more than 40 years and we are committed to sustain life as well as promoting healthcare through securing access to our high quality, affordable medicines and products. 

Group Business

ACDIMA is a value-based, R&D-driven Egyptian pharma group committed to bringing better health and a brighter future to people in Egypt & the region. Our group of companies covers diversified business solutions between world class pharmaceutical manufacturing, R&D, trading and integrated companies.

Investor Information

From Egypt to the world: Being the largest health care investment organization in Egypt, ACDIMA is well positioned in both developing and developed markets globally. We now have an expanding presence in Africa, Middle east, Europe and CIS countries.

We have a proud legacy dating back more than 40 years and we are committed to sustain life as well as promoting healthcare through securing access to our high quality, affordable medicines and products. 

untitled-1blue

Investor Information

From Egypt to the world: Being the largest health care investment organization in Egypt, ACDIMA is well positioned in both developing and developed markets globally. We now have an expanding presence in Africa, Middle east, Europe and CIS countries.

We have a proud legacy dating back more than 40 years and we are committed to sustain life as well as promoting healthcare through securing access to our high quality, affordable medicines and products. 

Group Business

ACDIMA is a value-based, R&D-driven Egyptian pharma group committed to bringing better health and a brighter future to people in Egypt & the region. Our group of companies covers diversified business solutions between world class pharmaceutical manufacturing, R&D, trading and integrated companies.

Investor Information

From Egypt to the world: Being the largest health care investment organization in Egypt, ACDIMA is well positioned in both developing and developed markets globally. We now have an expanding presence in Africa, Middle east, Europe and CIS countries.

We have a proud legacy dating back more than 40 years and we are committed to sustain life as well as promoting healthcare through securing access to our high quality, affordable medicines and products. 

untitled-1blue

We
Care

Stemming from our belief in the importance of corporate social responsibility and its importance in improving healthcare services to Egyptian patients and in cooperation with different governmental bodies.

THERAPEUTIC
LINES

Innovative products and pipeline, actively changing standards of care. ACDIMA pharmaceutical products cover 35 therapeutic classes maintaining the cGMP quality systems. See more than 900 products of ACDIMA.

News & Interviews